程序性死亡受体1抑制剂——替雷利珠单抗
A programmed death receptor-1 inhibitor——Tislelizumab
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 | 〉 |